Blockchain Registration Transaction Record

Nutriband Receives Patent for AVERSA Abuse-Deterrent Transdermal Technology in Macao

Nutriband (NTRB) receives patent in Macao for AVERSA abuse-deterrent transdermal technology. The innovative technology aims to reduce abuse, diversion, and accidental exposure of opioids. Learn more about Nutriband's efforts to address drug abuse.

This news matters as it highlights Nutriband's innovative efforts to address the abuse and misuse of transdermal drugs like opioids. The development of AVERSA technology has the potential to significantly impact the pharmaceutical industry by providing a solution to prevent abuse, diversion, and accidental exposure of drugs with abuse potential, ultimately contributing to public health and safety.